Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 14/20 | 0.68 |
| ▸ | DPP8 | Q6V1X1 | 9/20 | 0.56 |
| ▸ | DPP9 | Q86TI2 | 9/20 | 0.56 |
| ▸ | DPP7 | Q9UHL4 | 9/20 | 0.56 |
| ▸ | FAP | Q12884 | 7/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16572508 | 0.88 | DPP4 (0.67) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL24448607 | 0.88 | DPP4 (0.67) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL29477123 | 0.82 | DPP4 (0.68) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL8892192 | 0.82 | DPP4 (0.68) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL27369439 | 0.82 | DPP4 (0.68) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL8892200 | 0.82 | DPP4 (0.68) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL5336562 | 0.82 | DPP4 (0.68) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL7114188 | 0.82 | DPP4 (0.68) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL10792312 | 0.81 | DPP4 (0.67) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL30423009 | 0.79 | DPP4 (0.63) | DPP4DPP8DPP9DPP7FAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8357654-B2 | Multimeric CD40 ligands, method for preparing same and use thereof for preparing drugs | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2013-01-22 | — | — | US | disclosed |
| US-20100183642-A1 | NOVEL MULTIMERIC CD40 LIGANDS, METHOD FOR PREPARING SAME AND USE THEREOF FOR PREPARING DRUGS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2010-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100183642-A1 | NOVEL MULTIMERIC CD40 LIGANDS, METHOD FOR PREPARING SAME AND USE THEREOF FOR PREPARING DRUGS | CD40, CD40LG, TNFSF10 | DPP4 2432/4885DPP8 2820/4885DPP9 2466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.